Clinical Trial Update: Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation

View source ↗

Summary

A terminated clinical trial evaluating guided radiofrequency ablation using CARTO 3 and NavX systems for paroxysmal atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• CARTO 3
• NavX

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Paroxysmal Atrial Fibrillation | Status: TERMINATED | Results posted: 2014-07-21